LMOFX
Price
$47.68
Change
-$0.32 (-0.67%)
Updated
Oct 7 closing price
Net Assets
1.82B
VEXAX
Price
$159.56
Change
-$1.91 (-1.18%)
Updated
Oct 7 closing price
Net Assets
83.66B
Interact to see
Advertisement

LMOFX vs VEXAX

Header iconLMOFX vs VEXAX Comparison
Open Charts LMOFX vs VEXAXBanner chart's image
Patient Opportunity FI
Price$47.68
Change-$0.32 (-0.67%)
VolumeN/A
Net Assets1.82B
Vanguard Extended Market Index Admiral
Price$159.56
Change-$1.91 (-1.18%)
VolumeN/A
Net Assets83.66B
LMOFX vs VEXAX Comparison Chart in %
View a ticker or compare two or three
VS
LMOFX vs. VEXAX commentary
Oct 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LMOFX is a Hold and VEXAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEXAX has more cash in the bank: 83.7B vs. LMOFX (1.82B). VEXAX pays higher dividends than LMOFX: VEXAX (1.10) vs LMOFX (0.00). LMOFX was incepted earlier than VEXAX: LMOFX (22 years) vs VEXAX (25 years). LMOFX (1.83) is less costly to investors than VEXAX (0.05). LMOFX is a more actively managed with annual turnover of: 31.00 vs. VEXAX (11.00). LMOFX has a lower initial minimum investment than VEXAX: LMOFX (0) vs VEXAX (3000). LMOFX annual gain was more profitable for investors over the last year : 32.56 vs. VEXAX (18.45). VEXAX return over 5 years is better than : 56.47 vs. LMOFX (47.33).
LMOFXVEXAXLMOFX / VEXAX
Total Expense Ratio1.820.053,640%
Annual Report Gross Expense Ratio1.830.053,660%
Fund Existence22 years25 years-
Gain YTD21.76612.310177%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.82B83.7B2%
Annual Yield % from dividends0.001.10-
Returns for 1 year32.5618.45177%
Returns for 3 years82.1664.88127%
Returns for 5 years47.3356.4784%
Returns for 10 years133.46156.5385%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EDNMY12.30N/A
N/A
Edenred Malakoff
PTPIF0.53N/A
N/A
PT Chandra Asri Pacific Tbk
CSTAF11.52N/A
N/A
Constellation Acquisition Corp I
MAOFF1.61N/A
N/A
MAOYAN ENTMT
CSCIF2.55-0.14
-5.13%
COSCIENS Biopharma Inc